skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar solo
Refinado por: materia: Male eliminar
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)
Material Type:
Artículo 		Añadir a Mi Portal

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)

Charles, Pierre ; Terrier, Benjamin ; Perrodeau, Élodie ; Cohen, Pascal ; Faguer, Stanislas ; Huart, Antoine ; Hamidou, Mohamed ; Agard, Christian ; Bonnotte, Bernard ; Samson, Maxime ; Karras, Alexandre ; Jourde-Chiche, Noémie ; Lifermann, François ; Gobert, Pierre ; Hanrotel-Saliou, Catherine ; Godmer, Pascal ; Martin-Silva, Nicolas ; Pugnet, Grégory ; Matignon, Marie ; Aumaitre, Olivier ; Viallard, Jean-François ; Maurier, François ; Meaux-Ruault, Nadine ; Rivière, Sophie ; Sibilia, Jean ; Puéchal, Xavier ; Ravaud, Philippe ; Mouthon, Luc ; Guillevin, Loïc

Annals of the rheumatic diseases, 2018-08, Vol.77 (8), p.1143-1149 [Revista revisada por pares]

England: BMJ Publishing Group LTD

Texto completo disponible

Citas Citado por
2
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial
Material Type:
Artículo 		Añadir a Mi Portal

Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial

Matasar, Matthew J ; Capra, Marcelo ; Özcan, Muhit ; Lv, Fangfang ; Li, Wei ; Yañez, Eduardo ; Sapunarova, Katya ; Lin, Tongyu ; Jin, Jie ; Jurczak, Wojciech ; Hamed, Aryan ; Wang, Ming-Chung ; Baker, Ross ; Bondarenko, Igor ; Zhang, Qingyuan ; Feng, Jifeng ; Geissler, Klaus ; Lazaroiu, Mihaela ; Saydam, Guray ; Szomor, Árpád ; Bouabdallah, Krimo ; Galiulin, Rinat ; Uchida, Toshiki ; Soler, Lidia Mongay ; Cao, Anjun ; Hiemeyer, Florian ; Mehra, Aruna ; Childs, Barrett H ; Shi, Yuankai ; Zinzani, Pier Luigi

The lancet oncology, 2021-05, Vol.22 (5), p.678-689 [Revista revisada por pares]

England: Elsevier Ltd

Texto completo disponible

Citas Citado por
3
Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study
Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study
Material Type:
Artículo 		Añadir a Mi Portal

Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study

de Vos, S. ; Swinnen, L.J. ; Wang, D. ; Reid, E. ; Fowler, N. ; Cordero, J. ; Dunbar, M. ; Enschede, S.H. ; Nolan, C. ; Petrich, A.M. ; Ross, J.A. ; Salem, A.H. ; Verdugo, M. ; Agarwal, S. ; Zhou, L. ; Kozloff, M. ; Nastoupil, L.J. ; Flowers, C.R.

Annals of oncology, 2018-09, Vol.29 (9), p.1932-1938 [Revista revisada por pares]

England: Elsevier Ltd

Texto completo disponible

Citas Citado por
4
B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment
B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment
Material Type:
Artículo 		Añadir a Mi Portal

B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment

Fluge, Øystein ; Risa, Kristin ; Lunde, Sigrid ; Alme, Kine ; Rekeland, Ingrid Gurvin ; Sapkota, Dipak ; Kristoffersen, Einar Kleboe ; Sørland, Kari ; Bruland, Ove ; Dahl, Olav ; Mella, Olav van der Feltz-Cornelis, Christina

PloS one, 2015-07, Vol.10 (7), p.e0129898 [Revista revisada por pares]

United States: Public Library of Science

Texto completo disponible

Citas Citado por
5
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients
Material Type:
Artículo 		Añadir a Mi Portal

Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients

Pfreundschuh, Michael ; Murawski, Niels ; Zeynalova, Samira ; Ziepert, Marita ; Loeffler, M. ; Hänel, Matthias ; Dierlamm, Judith ; Keller, Ulrich ; Dreyling, Martin ; Truemper, Lorenz ; Frickhofen, Norbert ; Hünerlitürkoglu, Ali‐Nuri ; Schmitz, Norbert ; Pöschel, Viola ; Rixecker, Tanja ; Berdel, Christian ; Rübe, Christian ; Held, Gerhard ; Zwick, Carsten

British journal of haematology, 2017-11, Vol.179 (3), p.410-420 [Revista revisada por pares]

England: Blackwell Publishing Ltd

Texto completo disponible

Citas Citado por
6
Liver Immune Profiling Reveals Pathogenesis and Therapeutics for Biliary Atresia
Liver Immune Profiling Reveals Pathogenesis and Therapeutics for Biliary Atresia
Material Type:
Artículo 		Añadir a Mi Portal

Liver Immune Profiling Reveals Pathogenesis and Therapeutics for Biliary Atresia

Wang, Jun ; Xu, Yanhui ; Chen, Zhanghua ; Liang, Jiankun ; Lin, Zefeng ; Liang, Huiying ; Xu, Yiping ; Wu, Qi ; Guo, Xuanjie ; Nie, Junli ; Lu, Bingtai ; Huang, Bing ; Xian, Huifang ; Wang, Xiaohui ; Wu, Qiang ; Zeng, Jixiao ; Chai, Chengwei ; Zhang, Meixue ; Lin, Yuzhen ; Zhang, Li ; Zhao, Shanmeizi ; Tong, Yanlu ; Zeng, Liang ; Gu, Xiaoqiong ; Chen, Zhuang-gui ; Yi, Shuhong ; Zhang, Tong ; Delfouneso, David ; Zhang, Yan ; Nutt, Stephen L. ; Lew, Andrew M. ; Lu, Liwei ; Bai, Fan ; Xia, Huimin ; Wen, Zhe ; Zhang, Yuxia

Cell, 2020-12, Vol.183 (7), p.1867-1883.e26 [Revista revisada por pares]

United States: Elsevier Inc

Texto completo disponible

Citas Citado por
7
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
Material Type:
Artículo 		Añadir a Mi Portal

Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

Tilly, Hervé ; Morschhauser, Franck ; Sehn, Laurie H ; Friedberg, Jonathan W ; Trněný, Marek ; Sharman, Jeff P ; Herbaux, Charles ; Burke, John M ; Matasar, Matthew ; Rai, Shinya ; Izutsu, Koji ; Mehta-Shah, Neha ; Oberic, Lucie ; Chauchet, Adrien ; Jurczak, Wojciech ; Song, Yuqin ; Greil, Richard ; Mykhalska, Larysa ; Bergua-Burgués, Juan M ; Cheung, Matthew C ; Pinto, Antonio ; Shin, Ho-Jin ; Hapgood, Greg ; Munhoz, Eduardo ; Abrisqueta, Pau ; Gau, Jyh-Pyng ; Hirata, Jamie ; Jiang, Yanwen ; Yan, Mark ; Lee, Calvin ; Flowers, Christopher R ; Salles, Gilles

The New England journal of medicine, 2022-01, Vol.386 (4), p.351-363 [Revista revisada por pares]

United States: Massachusetts Medical Society

Texto completo disponible

Citas Citado por
8
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
Material Type:
Artículo 		Añadir a Mi Portal

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

Fervenza, Fernando C ; Appel, Gerald B ; Barbour, Sean J ; Rovin, Brad H ; Lafayette, Richard A ; Aslam, Nabeel ; Jefferson, Jonathan A ; Gipson, Patrick E ; Rizk, Dana V ; Sedor, John R ; Simon, James F ; McCarthy, Ellen T ; Brenchley, Paul ; Sethi, Sanjeev ; Avila-Casado, Carmen ; Beanlands, Heather ; Lieske, John C ; Philibert, David ; Li, Tingting ; Thomas, Lesley F ; Green, Dolly F ; Juncos, Luis A ; Beara-Lasic, Lada ; Blumenthal, Samuel S ; Sussman, Amy N ; Erickson, Stephen B ; Hladunewich, Michelle ; Canetta, Pietro A ; Hebert, Lee A ; Leung, Nelson ; Radhakrishnan, Jay ; Reich, Heather N ; Parikh, Samir V ; Gipson, Debbie S ; Lee, Dominic K ; da Costa, Bruno R ; Jüni, Peter ; Cattran, Daniel C

The New England journal of medicine, 2019-07, Vol.381 (1), p.36-46 [Revista revisada por pares]

United States: Massachusetts Medical Society

Texto completo disponible

Citas Citado por
9
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
Material Type:
Artículo 		Añadir a Mi Portal

CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma

Advani, Ranjana ; Flinn, Ian ; Popplewell, Leslie ; Forero, Andres ; Bartlett, Nancy L ; Ghosh, Nilanjan ; Kline, Justin ; Roschewski, Mark ; LaCasce, Ann ; Collins, Graham P ; Tran, Thu ; Lynn, Judith ; Chen, James Y ; Volkmer, Jens-Peter ; Agoram, Balaji ; Huang, Jie ; Majeti, Ravindra ; Weissman, Irving L ; Takimoto, Chris H ; Chao, Mark P ; Smith, Sonali M

The New England journal of medicine, 2018-11, Vol.379 (18), p.1711-1721 [Revista revisada por pares]

United States: Massachusetts Medical Society

Texto completo disponible

Citas Citado por
10
Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
Material Type:
Artículo 		Añadir a Mi Portal

Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

Shanafelt, Tait D ; Wang, Xin V ; Kay, Neil E ; Hanson, Curtis A ; O’Brien, Susan ; Barrientos, Jacqueline ; Jelinek, Diane F ; Braggio, Esteban ; Leis, Jose F ; Zhang, Cong C ; Coutre, Steven E ; Barr, Paul M ; Cashen, Amanda F ; Mato, Anthony R ; Singh, Avina K ; Mullane, Michael P ; Little, Richard F ; Erba, Harry ; Stone, Richard M ; Litzow, Mark ; Tallman, Martin

The New England journal of medicine, 2019-08, Vol.381 (5), p.432-443 [Revista revisada por pares]

United States: Massachusetts Medical Society

Texto completo disponible

Citas Citado por
Resultados 1 2 3 4 5 next page

Personalizar los resultados

  1. Editar

Refine Search Results

Ampliar mis resultados

  1.   

Mostrar solo

  1. Recursos en línea (7.770)
  2. Revistas arbitradas (7.673)

Refinar mis resultados

Tipo de Recurso 

  1. Artículos  (8.397)
  2. Actas de Congreso  (4)
  3. magazinearticle  (3)
  4. Capítulos de libro  (1)
  5. Más opciones open sub menu

Fecha de Publicación 

De Hasta
Refinar
  1. Antes de2001  (76)
  2. 2001Hasta2005  (660)
  3. 2006Hasta2010  (1.725)
  4. 2011Hasta2016  (3.402)
  5. Después de 2016  (2.543)
  6. Más opciones open sub menu

Idioma 

  1. Inglés  (7.953)
  2. Japonés  (1.111)
  3. Chino  (102)
  4. Español  (76)
  5. Francés  (73)
  6. Alemán  (50)
  7. Ruso  (24)
  8. Portugués  (23)
  9. Italiano  (15)
  10. Húngaro  (13)
  11. Czech  (6)
  12. Polaco  (6)
  13. Noruego  (5)
  14. Croatian  (3)
  15. Hebreo  (3)
  16. Danés  (3)
  17. Turco  (2)
  18. Holandés  (2)
  19. Ucraniano  (2)
  20. Bosnio  (1)
  21. Más opciones open sub menu

  • Realización: ABCD-USP USP   Logos de Redes Sociales: Freepik

Buscando en bases de datos remotas, por favor espere

  • Buscando por
  • enscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Mostrar lo que tiene hasta ahora